blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

Italy joins the Federated Register

Click here for more information on the Federated Register.

2025-06-12

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register User Manual
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2985026

EP2985026 - PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  01.07.2022
Database last updated on 31.03.2026
FormerGrant of patent is intended
Status updated on  20.02.2022
FormerExamination is in progress
Status updated on  14.12.2018
Most recent event   Tooltip14.03.2026Deletion: Date of oral proceedings 
Applicant(s)For all designated states
Besins Healthcare Luxembourg SARL
2-8 rue Julien Vesque
2668 Luxembourg / LU
[2025/10]
Former [2022/52]For all designated states
Tolmar, Inc.
701 Centre Ave
Fort Collins, CO 80526 / US
Former [2016/07]For all designated states
Clarus Therapeutics, Inc.
500 Skokie Boulevard, Suite 250
Northbrook, Illinois 60062 / US
Inventor(s)01 / Dudley, Robert
P.O. Box 611334
Rosemary Beach, Illinois 60031 / US
02 / Constantinides, Panayiotis
95 Berkshire Court
Gurnee, Illinois 60031 / US
 [2022/12]
Former [2016/07]01 / Dudley, Robert
P.O. Box 611334
Rosemary Beach, IL Illinois 60031 / US
02 / Constantinides, Panayiotis
95 Berskshire Court
Gurnee, IL Illinois 60031 / US
Representative(s)Steffan & Kiehne Patentanwälte PartG mbB
Burgplatz 21-22
40213 Düsseldorf / DE
[N/P]
Former [2022/31]Bridle, Andrew Barry
Bridle Intellectual Property Ltd
Unit 6F Thomas Way
Lake View Business Park
Sturry Road, Canterbury
Kent CT3 4JZ / GB
Former [2016/07]Grant, David Michael, et al
Marks & Clerk LLP
90 Long Acre
London WC2E 9RA / GB
Application number, filing date15186752.014.04.2006
[2016/07]
Priority number, dateUS20050671454P15.04.2005         Original published format: US 671454 P
US20050721971P30.09.2005         Original published format: US 721971 P
[2016/07]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2985026
Date:17.02.2016
Language:EN
[2016/07]
Type: B1 Patent specification 
No.:EP2985026
Date:03.08.2022
Language:EN
[2022/31]
Search report(s)(Supplementary) European search report - dispatched on:EP04.11.2015
ClassificationIPC:A61K31/568, A61K9/107, A61K47/12, A61K47/14, A61K47/44, A61P5/26, A61K31/573, A61K9/48, A61K31/22, A61P5/24, A61P15/00, A61P43/00, A61P15/16
[2022/10]
CPC:
A61K31/568 (EP,US); A61K31/573 (EP,KR,RU,US); A61K31/22 (EP,US);
A61K47/10 (US); A61K47/12 (US); A61K47/14 (EP,US);
A61K47/26 (US); A61K47/44 (RU,US); A61K9/0053 (US);
A61K9/06 (US); A61K9/20 (KR); A61K9/4858 (EP,US);
A61P15/00 (EP); A61P15/16 (EP); A61P43/00 (EP);
A61P5/24 (EP); A61P5/26 (EP); C07J1/00 (US);
A61K45/00 (RU); A61K9/1075 (EP,US); A61K9/50 (RU) (-)
C-Set:
A61K31/22, A61K2300/00 (EP,US);
A61K31/573, A61K2300/00 (US,EP)
Former IPC [2016/07]A61K31/568, A61K9/107, A61K47/12, A61K47/14, A61K47/44, A61P5/26
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/39]
Former [2016/07]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:SYSTEME ZUR PHARMAZEUTISCHEN VERABREICHUNG HYDROPHOBER WIRKSTOFFE UND ZUSAMMENSETZUNGEN DAMIT[2016/07]
English:PHARMACEUTICAL DELIVERY SYSTEMS FOR HYDROPHOBIC DRUGS AND COMPOSITIONS COMPRISING SAME[2016/07]
French:SYSTEMES D'ADMINISTRATION PHARMACEUTIQUE POUR DES MEDICAMENTS HYDROPHOBES ET LEURS COMPOSITIONS[2016/07]
Examination procedure17.08.2016Examination requested  [2016/39]
30.09.2016Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
12.12.2016Amendment by applicant (claims and/or description)
13.12.2018Despatch of a communication from the examining division (Time limit: M04)
12.04.2019Reply to a communication from the examining division
17.05.2019Despatch of a communication from the examining division (Time limit: M06)
26.11.2019Reply to a communication from the examining division
05.11.2020Despatch of a communication from the examining division (Time limit: M06)
14.05.2021Reply to a communication from the examining division
21.02.2022Communication of intention to grant the patent
23.06.2022Fee for grant paid
23.06.2022Fee for publishing/printing paid
23.06.2022Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06758358.3  / EP1871384
EP15165073.6  / EP2979699
Opposition(s)Opponent(s)01  26.04.2023  27.04.2023  ADMISSIBLE
Aera A/S
Niels Hemmingsens Gade 10, 5th floor
1153 Copenhagen K / DK
Opponent's representative
Bardehle Pagenberg S.L.
Avenida Diagonal 598, 3º, 1ª
08021 Barcelona / ES
 [2025/29]
Former [2023/22]
Opponent(s)01  26.04.2023  27.04.2023  ADMISSIBLE
Aera A/S
Niels Hemmingsens Gade 10, 5th floor
1153 Copenhagen K / DK
19.05.2023Invitation to proprietor to file observations on the notice of opposition
28.09.2023Reply of patent proprietor to notice(s) of opposition
26.11.2024Date of oral proceedings
19.12.2024Despatch of interlocutory decision in opposition
19.12.2024Despatch of minutes of oral proceedings
Appeal following opposition10.02.2025Appeal received No.  T0358/25
10.02.2025Payment of appeal fee
14.04.2025Statement of grounds filed
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
12.12.2016Request for further processing filed
12.12.2016Full payment received (date of receipt of payment)
Request granted
22.12.2016Decision despatched
Fees paidRenewal fee
06.10.2015Renewal fee patent year 03
06.10.2015Renewal fee patent year 04
06.10.2015Renewal fee patent year 05
06.10.2015Renewal fee patent year 06
06.10.2015Renewal fee patent year 07
06.10.2015Renewal fee patent year 08
06.10.2015Renewal fee patent year 09
06.10.2015Renewal fee patent year 10
27.04.2016Renewal fee patent year 11
27.04.2017Renewal fee patent year 12
27.04.2018Renewal fee patent year 13
29.04.2019Renewal fee patent year 14
27.04.2020Renewal fee patent year 15
27.04.2021Renewal fee patent year 16
27.04.2022Renewal fee patent year 17
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY14.04.2006
BG03.08.2022
EE03.08.2022
LT03.08.2022
LV03.08.2022
MC03.08.2022
SI03.08.2022
SK03.08.2022
IS03.12.2022
LU14.04.2023
[2025/36]
Former [2024/51]BG03.08.2022
EE03.08.2022
LT03.08.2022
LV03.08.2022
MC03.08.2022
SI03.08.2022
SK03.08.2022
IS03.12.2022
LU14.04.2023
Former [2024/08]EE03.08.2022
LT03.08.2022
LV03.08.2022
MC03.08.2022
SI03.08.2022
SK03.08.2022
IS03.12.2022
LU14.04.2023
Former [2024/04]EE03.08.2022
LT03.08.2022
LV03.08.2022
SI03.08.2022
SK03.08.2022
IS03.12.2022
LU14.04.2023
Former [2023/37]EE03.08.2022
LT03.08.2022
LV03.08.2022
SI03.08.2022
SK03.08.2022
IS03.12.2022
Former [2023/23]EE03.08.2022
LT03.08.2022
LV03.08.2022
SK03.08.2022
IS03.12.2022
Former [2023/12]LT03.08.2022
LV03.08.2022
IS03.12.2022
Former [2023/09]LT03.08.2022
LV03.08.2022
Former [2023/08]LT03.08.2022
Documents cited:Search[Y] WO9740823  (SCHERER LTD R P et al.)
 [Y] WO0059482  (SCHERER CORP R P et al.)
 [Y] WO0059512  (AKZO NOBEL NV et al.)
 [Y] US2002012680  (PATEL MAHESH V et al.)
 [Y] US5645856  (LACY JONATHAN ERNEST et al.)
 [Y] US4147783  (VAN DER VIES JOHANNES et al.) [Y] 1-6 * claims 1,2,13-17 * * page 3, lines 20-24 * * page 4, line 4 - page 5, line 6 * * examples 21-38 *
OppositionWO9740823
 WO2005076899
   F D GUNSTONE: "Gamma-linolenic Acid", ENCYCLOPEDIA OF FOOD SCIENCES AND NUTRITION, 2003, pages 2308 - 2311, XP093089001
   TEHMING LIANG, SHUTSUNG LIAO: "Growth Suppression of Hamster Flank Organs by Topical Application of y-Linolenic and Other Fatty Acid Inhibitors of Sa-Reductase", JOURNAL OF INVESTIGATIVE DERMATOLOGY, vol. 109, no. 2, 1 August 1997 (1997-08-01), pages 152 - 157, XP093089007
   DRESSER GEORGE K., WACHER VINCENT, WONG SUSAN, WONG HARRISON T., BAILEY DAVID G.: "Evaluation of peppermint oil and ascorbyl palmitate as inhibitors of cytochrome P4503A4 activity in vitro and in vivo", CLINICAL PHARMACOLOGY AND THERAPEUTICS, vol. 72, no. 3, 1 September 2002 (2002-09-01), US , pages 247 - 255, XP093089010, ISSN: 0009-9236, DOI: 10.1067/mcp.2002.126409

DOI:   http://dx.doi.org/10.1067/mcp.2002.126409
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.